Vente Unique.com (ALVU)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 14.40 |
|---|---|
| 52-week range | 13.00 – 17.90 |
| Return, 1 month / 3 months | −14.0% / −14.0% |
| Return, 1 year / 3 years | −3.6% / +46.3% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 32.1% |
| Worst drawdown (1 year) | -27.4% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vente-unique.com is a French online retailer of furniture and home furnishings. The company sells sofas, beds, mattresses, tables, chairs, storage units and outdoor furniture through its own website, along with decorative items for the home. Its customers are households across several European countries who order furniture online for delivery to their homes. The business is based in the north of France and runs its operations around its e-commerce platform and logistics.
The shares are listed on the Euronext Paris in France under the code ALVU, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vente Unique.com (ALVU) trades on the Euronext Paris in France. It last closed at EUR 14.40 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 211 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.6% and over the last three months it fell 14.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.1% | ||
| From 52-week high | -19.6% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -14.0% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | 12.1% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.4% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −14.0% |
| 3 months | −14.0% |
| 6 months | +3.4% |
| 1 year | −3.6% |
| 3 years | +46.3% |
| 5 years | −1.6% |
Signals
| 50-day / 200-day average | 16.26 / 15.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | EUR 0.5000 |
| 3 Jun 2025 | EUR 0.3800 |
| 20 Jun 2024 | EUR 0.4200 |
| 25 May 2023 | EUR 0.2200 |
| 16 Dec 2022 | EUR 0.2800 |
| 27 Apr 2021 | EUR 0.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.